1. 63 10 year follow-up study of the long term effects of ANTI-TNF therapyon bone metabolism in a cohort of ANTI-TNF naïve IBD patients. (5th April 2017) Authors: O'Morain, N; Farrell, G; Stack, R; Hussey, M; Bailey, Y; Kiat, C; Veerappan, S; McNamara, D; O'Connor, A; Breslin, N; O'Morain, C; Ryan, BM Journal: Gut Issue: Volume 66(2017)Supplement 1 Page Start: A23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Issue 4 (20th April 2013) Authors: Burisch, J; Pedersen, N; Čuković-Čavka, S; Brinar, M; Kaimakliotis, I; Duricova, D; Shonová, O; Vind, I; Avnstrøm, S; Thorsgaard, N; Andersen, V; Krabbe, S; Dahlerup, J F; Salupere, R; Nielsen, K R; Olsen, J; Manninen, P; Collin, P; Tsianos, E V; Katsanos, K H Journal: Gut Issue: Volume 63:Issue 4(2014) Page Start: 588 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P607 HLA-DQA1*05 Allele Carriage and Anti-TNF Therapy Persistence in Inflammatory Bowel Disease. (30th January 2023) Authors: Doherty, J; Ryan, A; Quinn, E; Dolan, J; Corcoran, R; O' Hara, F; Bailey, Y; McNamara, D; Doherty, G; Kevans, D Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i734 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗